Franklin Biotechnology Disc A Acc $

Performance History31/03/2014
Growth of 1,000 (EUR)
Franklin Biotechnology Disc A Acc $
Fund25.813.324.957.27.4
+/-Cat8.211.40.26.00.4
+/-Idx15.8-5.6-16.9-3.36.9
 
Key Stats
NAV
17/04/2014
 USD 22.65
Day Change -0.30%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0109394709
Fund Size (Mil)
31/03/2014
 USD 3199.62
Share Class Size (Mil)
31/03/2014
 USD 2712.82
Max Initial Charge 5.75%
Total Expense Ratio
28/02/2014
  1.82%
Investment Objective: Franklin Biotechnology Disc A Acc $
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns17/04/2014
YTD-3.23
3 Years Annualised28.29
5 Years Annualised23.08
10 Years Annualised9.33
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Jerel Banks
01/09/2012
Inception Date
03/04/2000
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Disc A Acc $31/01/2014
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks90.970.0090.97
Bonds0.000.000.00
Cash8.950.008.95
Other0.070.000.07
Top 5 Regions%
United States96.18
United Kingdom2.35
Canada0.98
Eurozone0.50
Asia - Developed0.00
Top 5 Sectors%
No Data Available
Top 5 HoldingsSector%
Gilead Sciences IncHealthcareHealthcare9.22
Biogen Idec IncHealthcareHealthcare6.52
Celgene CorporationHealthcareHealthcare5.57
Amgen IncHealthcareHealthcare5.41
Medivation, Inc.HealthcareHealthcare4.33
Franklin Biotechnology Disc A Acc $